Psychiatric and behavioral manifestations of lysosomal storage disorders

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 7, 2010, Pages 1253-1265

  Staretz Chacham, Orna ^a   Choi, Jae Hyuk ^a   Wakabayashi, Kazuyo ^a   Lopez, Grisel ^a   Sidransky, Ellen ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Behavioral abnormalities; Enzyme deficiency; Genetic disorders; Lysosomal storage disorders; Psychiatric disorders

Indexed keywords

AGGRESSIVENESS; ASPARTYLGLYCOSAMINURIA; BETA MANNOSIDOSIS; DEMENTIA; ENZYME REPLACEMENT; FABRY DISEASE; GAUCHER DISEASE; GENE MUTATION; GENE THERAPY; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; LYSOSOME STORAGE DISEASE; MANNOSIDOSIS; METACHROMATIC LEUKODYSTROPHY; MOOD DISORDER; MUCOPOLYSACCHARIDOSIS; NEURONAL CEROID LIPOFUSCINOSIS; NIEMANN PICK DISEASE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; TAY SACHS DISEASE;

HUMANS; LYSOSOMAL STORAGE DISEASES; MENTAL DISORDERS; PSYCHOTIC DISORDERS;

EID: 77957366083     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31097     Document Type: Review

References (82)

1. Aicardi J. 1993. The inherited leukodystrophies: A clinical overview. J Inherit Metab Dis 16(4):733-743.
2. Arvio P, Arvio M. 2002. Progressive nature of aspartylglucosaminuria. Acta Paediatr 91(3):255-257.
3. Arvio M, Autio S, Louhiala P. 1993. Early clinical symptoms and incidence of aspartylglucosaminuria in Finland. Acta Paediatr 82(6-7):587-589.
4. Ashworth JL, Biswas S, Wraith E, Lloyd IC. 2006. Mucopolysaccharidoses and the eye. Surv Ophthalmol 51(1):1-17.
5. Aula P, Jalanko A, Peltonen L. 2001. Aspartylglucosaminuria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 3535-3550.
6. Backman ML, Santavuori PR, Aberg LE, Aronen ET. 2005. Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis. J Intellect Disabil Res 49(Pt1): 25-32.
7. Baumann N, Masson M, Carreau V, Lefevre M, Herschkowitz N, Turpin JC. 1991. Adult forms of metachromatic leukodystrophy: Clinical and biochemical approach. Dev Neurosci 13(4-5):211-215.
8. Bax MC, Colville GA. 1995. Behaviour in mucopolysaccharide disorders. Arch Dis Child 73(1):77-81.
9. Bedilu R, Nummy KA, Cooper A, Wevers R, Smeitink J, Kleijer WJ, Friderici KH. 2002. Variable clinical presentation of lysosomal beta-mannosidosis in patients with null mutations. Mol Genet Metab 77(4):282-290.
10. Berger-Plantinga EG, Vanneste JA, Groener JE, van Schooneveld MJ. 2004. Adult-onset dementia and retinitis pigmentosa due to mucopolysaccharidosis III-C in two sisters. J Neurol 251(4):479-481.
11. Beutler E, Grabowski GA. 2001. Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 3635-3668.
12. Blom TS, Linder MD, Snow K, Pihko H, Hess M, Jokitalo E, Veckman V, Syvanen AC, Ikonen E. 2003. Defective endocytic trafficking of NPC1 and NPC2 underlying infantile Niemann-Pick type C disease. Hum Mol Genet 12:257-272.
13. Butler RW, Light R. 2003. Late diagnosis of neurodegenerative disease in children: Anosognosia by proxy. Clin Neuropsychol 17(3):374-382.
14. Champion KJ, Basehore MJ, Wood T, Destree A, Vannuffel P, Maystadt I. 2010. Identification and characterization of a novel homozygous deletion in the alpha-N-acetylglucosaminidase gene in a patient with Sanfilippo type B syndrome (mucopolysaccharidosis IIIB). Mol Genet Metab 100:51-56.
15. Cleary MA, Wraith JE. 1993. Management of mucopolysaccharidosis type III. Arch Dis Child 69(3):403-406.
16. Cleary MA, Wraith JE. 1995. The presenting features of mucopolysaccharidosis type IH (Hurler syndrome). Acta Paediatr 84(3):337-339.
17. Cole AL, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH. 2007. Depression in adults with Fabry disease: A common and under-diagnosed problem. J Inherit Metab Dis 30(6):943-951.
18. Deconinck N, Messaaoui A, Ziereisen F, Kadhim H, Sznajer Y, Pelc K, Nassogne MC, Vanier MT, Dan B. 2008. Metachromatic leukodystrophy without arylsulfatase A deficiency: A new case of saposin-B deficiency. Eur J Paediatr Neurol 12(1):46-50.
19. Elstein D, Doniger GM, Simon E, Korn-Lubetzki I, Navon R, Zimran A. 2008. Neurocognitive testing in late-onset Tay-Sachs disease: A pilot study. J Inherit Metab Dis 31(4):518-523.
20. Estrov Y, Scaglia F, Bodamer OA. 2000. Psychiatric symptoms of inherited metabolic disease. J Inherit Metab Dis 23(1):2-6.
21. Fraser J, Wraith JE, Delatycki MB. 2002. Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): A survey of managing clinicians. Clin Genet 62(5):418-421.
22. Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E. 2008a. The spectrum of Parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65(10):1353-1357.
23. Goker-Alpan O, Wiggs EA, Eblan MJ, Benko W, Ziegler SG, Sidransky E, Schiffmann R. 2008b. Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease. J Pediatr 153(1):89-94.
24. Goodman AB. 1994. Medical conditions in Ashkenazi schizophrenic pedigrees. Schizophr Bull 20(3):507-517.
25. Gort L, Duque J, Fabeiro JM, Zulaica A, Coll MJ, Chabas A. 2006. Molecular analysis in two beta-mannosidosis patients: Description of a new adult case. Mol Genet Metab 89(4):398-400.
26. M2 gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 3827-3876.
27. Grewal RP. 1993. Psychiatric disorders in patients with Fabry's disease. Int J Psychiatry Med 23(3):307-312.
28. Guggenbuhl P, Grosbois B, Chalès G. 2008. Gaucher disease. Joint Bone Spine 75(2):116-124.
29. Herrlin KM, Hillborg PO. 1962. Neurological signs in a juvenile form of Gaucher's disease. Acta Paediatr 51:137-154.
30. Hoffmann B, Beck M, Sunder-Plassmann G, Borsini W, Ricci R, Mehta A. 2007. Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy - A retrospective analysis from the Fabry Outcome Survey. Clin J Pain 23(6):535-542.
31. Hurowitz G, Silver J, Brin M, Williams D, Johnson W. 1993. Neuropsychiatric aspects of adult-onset Tay-Sachs disease: Two case reports with several new findings. J Neuropsychiatry Clin Neurosci 5(1):30-36.
32. Hyde TM, Ziegler JC, Weinberger DR. 1992. Psychiatric disturbances in metachromatic leukodystrophy: Insights into the neurobiology of psychosis. Arch Neurol 49(4):401-406.
33. Jalanko A, Braulke T. 2009. Neuronal ceroid lipofuscinoses. Biochim Biophys Acta 1793(4):697-709.
34. Labauge P, Renard D, Castelnovo G, Sabourdy F, de Champfleur N, Levade T. 2009. Beta-mannosidosis: A new cause of spinocerebellar ataxia. Clin Neurol Neurosurg 111(1):109-110.
35. Levade T, Graber D, Flurin V, Delisle MB, Pieraggi MT, Testut MF, Carriere JP, Salvayre R. 1994. Human beta-mannosidase deficiency associated with peripheral neuropathy. Ann Neurol 35(1):116-119.
36. Lichtenberg P, Navon R, Wertman E, Dasberg H, Lerer B. 1988. Postpartum psychosis in adult GM2 gangliosidosis. A case report. Br J Psychiatry 153:387-389.
37. MacQueen GM, Rosebush PI, Mazurek MF. 1998. Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci 10(1):10-19.
38. Malm D, Nilssen O. 2008. Alpha-mannosidosis. Orphanet J Rare Dis 3:21.
39. Malm D, Pantel J, Linaker OM. 2005. Psychiatric symptoms in alphamannosidosis. J Intellect Disabil Res 49(Pt11): 865-871.
40. Martins AM, D'Almeida V, Kyosen SO, Takata ET, Delgado AG, Goncalves AM, Benetti Filho CC, Martini Filho D, Biagini G, Pimentel H, et al. 2009. Guidelines to diagnosis and monitoring of Fabry disease and review of treatment experiences. J Pediatr 155(4Suppl): S19-S31.
41. Mole SE, Williams RE, Goebel HH. 2005. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6(3):107-126.
42. Mononen I, Ylikangas P, Mononen T, Savolainen K. 1994. Neonatal detection of aspartylglycosaminuria. Lancet 343(8908):1297-1298.
43. Moog U, van Mierlo I, van Schrojenstein Lantman-de Valk HM, Spaapen L, Maaskant MA, Curfs LM. 2007. Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems? Am J Med Genet Part C 145C(3):293-301.
44. Navon R, Argov Z, Frisch A. 1986. Hexosaminidase A deficiency in adults. Am J Med Genet 24(1):179-196.
45. Neil JF, Glew RH, Peters SP. 1979. Familial psychosis and diverse neurologic abnormalities in adult-onset Gaucher's disease. Arch Neurol 36(2):95-99.
46. Neudorfer O, Pastores GM, Zeng BJ, Gianutsos J, Zaroff CM, Kolodny EH. 2005. Late-onset Tay-Sachs disease: Phenotypic characterization and genotypic correlations in 21 affected patients. Genet Med 7(2):119-123.
47. Neufeld EF, Muenzer J. 2001. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 3421-3452.
48. Nijssen PC, Brusse E, Leyten AC, Martin JJ, Teepen JL, Roos RA. 2002. Autosomal dominant adult neuronal ceroid lipofuscinosis: Parkinsonism due to both striatal and nigral dysfunction. Mov Disord 17(3):482-487.
49. Orchard PJ, Tolar J. 2010. Transplant outcomes in leukodystrophies. Semin Hematol 47(1):70-78.
50. Patterson MC, et al. 2001. Niemann-Pick disease type C: A lipid trafficking disorder. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 3611-3633.
51. Peiffer J. 1959. On metachromatic leukodystrophy (Scholz type). Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr 199:386-416.
52. Perez-Calvo J, Bernal M, Giraldo P, Torralba MA, Civeira F, Giralt M, Pocovi M. 2000. Co-morbidity in Gaucher's disease results of a nationwide enquiry in Spain. Eur J Med Res 5(6):231-235.
53. Raja M, Azzoni A, Giona F, Regis S, Grossi S, Filocamo M, Sidransky E. 2007. Movement and mood disorder in two brothers with Gaucher disease. Clin Genet 72(4):357-361.
54. Renshaw PF, Stern TA, Welch C, Schouten R, Kolodny EH. 1992. Electro-convulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis. Ann Neurol 31(3):342-344.
55. Rosebush PI, MacQueen GM, Clarke JT, Callahan JW, Strasberg PM, Mazurek MF. 1995. Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: Diagnostic and treatment issues. J Clin Psychiatry 56(8):347-353.
56. Ruijter GJ, Valstar MJ, van de Kamp JM, van der Helm RM, Durand S, van Diggelen OP, Wevers RA, Poorthuis BJ, Pshezhetsky AV, Wijburg FA. 2008. Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in the Netherlands. Mol Genet Metab 93(2):104-111.
57. Sabourdy F, Labauge P, Stensland HM, Nieto M, Garces VL, Renard D, Castelnovo G, de Champfleur N, Levade T. 2009. A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: A possible pseudodeficiency variant. BMC Med Genet 10:84.
58. Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J. 2004. Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14(4):199-201.
59. Saito S, Ohno K, Sugawara K, Suzuki T, Togawa T, Sakuraba H. 2008. Structural basis of aspartylglucosaminuria. Biochem Biophys Res Commun 377(4):1168-1172.
60. Sandu S, Jackowski-Dohrmann S, Ladner A, Haberhausen M, Bachmann C. 2009. Niemann-Pick disease type C1 presenting with psychosis in an adolescent male. Eur Child Adolesc Psychiatry 18(9):583-585.
61. Santavuori P, Linnankivi T, Jaeken J, Vanhanen SL, Telakivi T, Heiskala H. 1993. Psychological symptoms and sleep disturbances in neuronal ceroid-lipofuscinoses (NCL). J Inherit Metab Dis 16(2):245-248.
62. Santavuori P, Vanhanen SL, Autti T. 2001. Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders. Eur J Paediatr Neurol 5(Suppl A): 157-161.
63. Schiffmann R. 2009. Fabry disease. Pharmacol Ther 122(1):65-77.
64. Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D. 2007. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis 30(5):631-641.
65. Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, Sedel F. 2007. The adult form of Niemann-Pick disease type C. Brain 130(Pt1):120-133.
66. Shapiro BE, Pastores GM, Gianutsos J, Luzy C, Kolodny EH. 2009. Miglustat in late-onset Tay-Sachs disease: A 12-month, randomized, controlled clinical study with 24 months of extended treatment. Genet Med 11(6):425-433. 10.1097/GIM.0b013e3181a1b5c5.
67. Sidransky E. 2004. Gaucher disease: Complexity in a "simple" disorder. Mol Genet Metab 83(1-2):6-15.
68. Simonati A, Tessa A, Bernardina BD, Biancheri R, Veneselli E, Tozzi G, Bonsignore M, Grosso S, Piemonte F, Santorelli FM. 2009. Variant late infantile neuronal ceroid lipofuscinosis because of CLN1 mutations. Pediatr Neurol 40(4):271-276.
69. Sourander P. 1962. Histopathological studies in sulphatide lipidosis (metachromatic leukodystrophy). Acta Pathol Microbiol Scand Suppl 154:83-85.
70. Streifler J, Golomb M, Gadoth N. 1989. Psychiatric features of adult GM2 gangliosidosis. Br J Psychiatry 155:410-413.
71. Thomas GH. 2001. Disorders of glycoprotein degradation: α-Mannosidosis, b-mannosidosis, fucosidosis, and sialidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 3507-3533.
72. Thomas CM, Morris S. 2003. Cost of depression among adults in England in 2000. Br J Psychiatry 183:514-519.
73. Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA. 2008. Sanfilippo syndrome: A mini-review. J Inherit Metab Dis 31:240-252.
74. van Diggelen OP, Thobois S, Tilikete C, Zabot MT, Keulemans JL, van Bunderen PA, Taschner PE, Losekoot M, Voznyi YV. 2001. Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: First adult-onset patients of a childhood disease. Ann Neurol 50(2):269-272.
75. Vargas-Diez E, Chabas A, Coll MJ, Sanchez-Perez J, Garcia-Diez A, Fernandez-Herrera JM. 2002. Angiokeratoma corporis diffusum in a Spanish patient with aspartylglucosaminuria. Br J Dermatol 147(4):760-764.
76. von Figura K, et al. 2001. Metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 3695-3724.
77. Watanabe A, Miyazaki H, Katoh H, Hukui K, Hori H, Hirase H, Haraki T, Hirata M, Ohta M. 2007. Hunter syndrome with obstructive sleep apnea in patient who had received psychiatry treatment for insomnia and suicidal ideas. Nippon Naika Gakkai Zasshi 96(2):338-340.
78. Wolanczyk T, Banaszkiewicz A, Mierzewska H, Czartoryska B, Zdziennicka E. 2000. Hyperactivity and behavioral disorders in Sanfilippo A (mucopolysaccharidosis type IIIA) - Case report and review of the literature. Psychiatr Pol 34(5):831-837.
79. Wraith JE, Rogers JG, Danks DM. 1987. The mucopolysaccharidoses. Aust Paediatr J 23(6):329-334.
80. Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, Pineda M, Sedel F, Topcu M, Vanier MT, et al. 2009. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab 98(1-2):152-165.
81. Wulff CH, Trojaborg W. 1985. Adult metachromatic leukodystrophy: Neurophysiologic findings. Neurology 35(12):1776-1778.
82. Yanjanin NM, Velez JI, Gropman A, King K, Bianconi SE, Conley SK, Brewer CC, Solomon B, Pavan WJ, Arcos-Burgos M, et al. 2010. Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am J Med Genet Part B 153B(1):132-140.